To record your attendance at the SDWG Conference Call, click the sign-on button to the right:


Facilitator:

Andrew Statler


Date:


Call Details:

Zoom Information

https://us02web.zoom.us/j/465862913?pwd=cUllR1BndVpYNVpyR3dzc3VIUERTZz09

Meeting ID: 465 862 913

Passcode: 310940

Phone Information:

+1 312 626 6799 US (Chicago)
+1 929 436 2866 US (New York)
+1 301 715 8592 US (Germantown)
+1 346 248 7799 US (Houston)
+1 669 900 6833 US (San Jose)
+1 253 215 8782 US (Tacoma)
Find your local number: https://us02web.zoom.us/u/kb1hK2eKvz



Attendees:


Meeting Attendance

To add your name to the attendance, exit Edit mode for this page and then click on the Submit button at the top of the page. Once you have submitted your attendance, the screen will indicate that you have already signed-in. Thank you!

Name

Name

Affiliation

E-mail

Owned By

Records: 0

Agenda:


10:00am ET

  1. Call to order 
    1. Call for Attendance

  2. Business Updates (10 min)
    1. Additions/modifications to the agenda
    2. Approve minutes from2020-11-05 Agenda and Minutes

    3. HL7
  3. Review Project Proposals
    1. Project Proposals Home
  4. External Updates - ONC and others
  5. Project Updates
  6. C-CDA - Roadmap: Errata Updates, changes, long-term plans
  7. Additional Items
    1. Appoint Interim Co-chair(s)
    2. Development of C-CDA Road Map Team
    3. Reballot of C-CDA on FHIR for "Mapping Rules" esp wrt participant mappings within the resources - recurring topic  (Gay Dolin or Lisa R. Nelson )- may be absorbed into Road Map topic
      1. PCWG/SD/FHIR I notes: 2020 Sept WGM Patient Care Agenda and Minutes
    4. Jan. WGM Meeting Room Request (due Monday 11/16)
      1. What Joint sessions do we need to host?
    5. Stylesheet Package Errata and Jira Migration Lisa R. Nelson
      1. SDWG asset review.xlsx
  8. STU Comments [ Comment Tracker ]
    1. HL7 CDA® R2 IG: C-CDA Templates for Clinical Notes DSTU Release 2 & 2.1 - US Realm
    2. 2063 http://www.hl7.org/dstucomments/showdetail.cfm?dstuid=223Natasha Kreisle
    3. Personal Advance Care Plan (2062 http://www.hl7.org/dstucomments/showdetail.cfm?dstuid=296) (Natasha Kreisle)
    4. STU Comment 2061 From Brett Marquard to Everyone: 08:04 AM
      http://www.hl7.org/dstucomments/showdetail_comment.cfm?commentid=2061
  9. FHIR Tickets [ JIRA ]

Notes/Minutes:


10:05am ET

  1. Call to order 
    1. Call for Attendance

  2. Business Updates (10 min)
    1. Additions/modifications to the agenda
    2. Approve minutes from2020-11-05 Agenda and Minutes

    3. Minutes approved by silent consensus
    4. HL7
TypeMotion
Motion

Motion to approve: Approve Russell Ottas an interim co-chair

By
Second
Date

11/12/2020

Ref #
For22
Neg0
Abs0
Status

APPROVED

Tally22-00-00 
Discussion

No discussion

Action

Gay Dolinto notify HQ that we've appointed an interim

  1. Review Project Proposals
    1. Project Proposals Home
    2. Commented on the FHIR Implementation Guide to migrate from SPL V3 to a FHIR-based submission architecture identifying SDWG is would be an interested party.
  2. External Updates - ONC and others
    1. None
  3. Project Updates
  4. C-CDA - Roadmap: Errata Updates, changes, long-term plans
  5. Additional Items
    1. Development of C-CDA Road Map Team
      1. Forming a task force to flesh out the C-CDA Roadmap. Call for participation in a series of weekly meetings for the next month or so.
    2. Reballot of C-CDA on FHIR for "Mapping Rules" esp wrt participant mappings within the resources - recurring topic  (Gay Dolin or Lisa R. Nelson )- may be absorbed into Road Map topic
      1. PCWG/SD/FHIR I notes: 2020 Sept WGM Patient Care Agenda and Minutes
      2. No discussion today
    3. Jan. WGM Meeting Room Request (due Monday 11/16)
      1. What Joint sessions do we need to host?
        1. Still want a separate Joint with FHIR I to talk about FHIR Logical model for CDA
        2. CDAMG need to coordinate a time
        3. Joint with CTO and his team to discuss CDA tooling
      2. Join FHIR-I W Q3
      3. In general schedule 4 quarters each day M-Th
      4. Austin Kreisler will enter our meeting room request in the system
  6. STU Comments [ Comment Tracker ]
    1. HL7 CDA® R2 IG: C-CDA Templates for Clinical Notes DSTU Release 2 & 2.1 - US Realm
    2. 2063 http://www.hl7.org/dstucomments/showdetail.cfm?dstuid=223Natasha Kreisle
      1. TypeMotion
        Motion

        Motion to approve 

        November 12, 2020: A chart/table needs to be developed in place of the current text. Motion: made by Natasha/Calvin seconded. Motion carries 21/0/0

        By
        Second
        Date

         

        Ref #
        For21
        Neg0
        Abs0
        Status

        APPROVED

        Tally21-00-00 
        Discussion

        Action
    3. 2064 Advanced Directives Natasha Kreisle

      TypeMotion
      Motion

      Motion to approve 

      November 12, 2020 The typo will be corrected. Motion Made by Natasha/ seconded by Calvin: Motion carries 21/0/0

      By
      Second
      Date

       

      Ref #
      For21
      Neg0
      Abs0
      Status

      APPROVED

      Tally21-00-00 
      Discussion

      Action
    4. STU Comment 2061 From Brett Marquard to Everyone: 08:04 AM
      http://www.hl7.org/dstucomments/showdetail_comment.cfm?commentid=2061
      1. TypeMotion
        Motion

        Motion to approve STU comment 2061 approved as Errata

        CVX Value set will be re-expanded to reflect updated codes in the CVX code system values present in VSAC. This will bring in at least the 197 code. Motion Made by: Brett/ Seconded by Calvin - 24/0/0

        By
        Second
        Date

         

        Ref #
        For24
        Neg0
        Abs0
        Status

        APPROVED

        Tally24-00-00 
        Discussion

        Action

        Rob McClure to work making the VSAC update and then will work with Lisa R. Nelson to advance the errata

  7. FHIR Tickets [ JIRA ]

 


*Tip


Copyright © Health Level Seven International ® ALL RIGHTS RESERVED. The reproduction of this material in any form is strictly forbidden without the written permission of the publisher.